Patients With Bladder Cancer May Avoid Removal of Extra Lymph Nodes, Study Finds
WEDNESDAY, June 7, 2023 (HealthDay News) — For years, doctors have thought that a more extensive surgery that removes a wider swath of lymph nodes was the best option for certain patients with bladder cancer. Now, a new clinical trial is upending tha…
Learn MoreGene-Targeted Drug Tagrisso Cuts Death Rate in Half for Patients With Early-Stage Lung Cancer
TUESDAY, June 6, 2023 (HealthDay News) — Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows.The results could have m…
Learn MoreCould a Nitroglycerin Patch Ease Hot Flashes?
TUESDAY, June 6, 2023 (HealthDay News) — A new study on using nitroglycerin patches to help women with frequent hot flashes caused by menopause has delivered mixed results. The benefits of wearing these patches — long used as chest pain medication — …
Learn MoreNew Drug Could Be Advance Against Glioma Brain Tumors
MONDAY, June 5, 2023 (HealthDay News) — An experimental targeted therapy can dramatically slow the progress of common slow-growing brain cancers, a new clinical trial finds.The oral drug vorasidenib nearly tripled progression-free survival in patient…
Learn MoreIs a Liver Dialysis Device on the Horizon?
FRIDAY, June 2, 2023 (HealthDay News) — A new liver dialysis device might soon be able to save patients on the edge of death from liver failure, early clinical trial results show.The DIALIVE device safely improved organ function and alleviated sympto…
Learn MoreEligibility Criteria May Influence Disparity in Multiple Myeloma Trial Enrollment
MONDAY, May 8, 2023 (HealthDay News) — Eligibility criteria may contribute to racial and ethnic disparities in enrollment in multiple myeloma (MM) clinical trials, according to a study published online May 4 in Blood.Bindu Kanapuru, M.D., from the U….
Learn MoreUna nueva forma de levodopa podría mejorar la atención del Parkinson
MIÉRCOLES, 26 de abril de 2023 (HealthDay News) — Una versión de liberación prolongada de un medicamento para la enfermedad de Parkinson podría ofrecer un alivio más estable a los pacientes que padecen el trastorno del movimiento, muestran los datos …
Learn MoreNew Form of Levodopa Might Improve Parkinson’s Care
WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show.The new formulation of levodopa, called IPX2…
Learn MoreNew Form of Levodopa Might Improve Parkinson’s Care
WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show.The new formulation of levodopa, called IPX2…
Learn MoreBlood Donors’ Gender Doesn’t Affect Outcomes for Recipients
THURSDAY, April 13, 2023 (HealthDay News) — Whether the gender of a blood donor could affect the recipient’s survival was an unanswered question in medicine. Until now.“Some observational studies had suggested female donor blood might be linked with …
Learn More